We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients (MAMOC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04227522
Recruitment Status : Recruiting
First Posted : January 13, 2020
Last Update Posted : September 5, 2021
Sponsor:
Collaborators:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Clovis Oncology, Inc.
Information provided by (Responsible Party):
North Eastern German Society of Gynaecological Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2023
Estimated Study Completion Date : January 2025